Contact Us
TEL: +86-0571-88334626
E-mail: sales@tacon-china.com.cn

AZD9291

Structure : Description : Osimertinib (previously known as mereletinib or AZD9291; trade name Tagrisso) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug developed by AstraZeneca Pharmaceuticals – for mutated EGFR cancers. We can provide this...

  • Features & Specification

    PRODUCT NAME

    AZD9291

    CAS No.:

    1421373-65-0

    Synonyms

    N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide

    Formula

    C28H33N7O2

    Molecular Weight

    499.60700

    PSA:

    87.55000

    LogP:

    4.65580

    Structure: 

    15.png

    Description
    Osimertinib (previously known as mereletinib or AZD9291; trade name Tagrisso) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug developed by AstraZeneca Pharmaceuticals – for mutated EGFR cancers.
    We can provide this product with assay 99%.

Hot Tags: AZD9291, China, manufacturers, suppliers, factory, buy, customized, custom product, contract product
Related Products
Inquiry